Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
November 8, 2017
Interfering with DNA High-Order Structures using Chiral Ruthenium(II) Complexes
Shanshan Zou, Guanying Li, Thomas W Rees, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2010
Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis
Huabang Zhou, Hui Wang, Dongxun Zhou, et al.
Scientific Reports
|
July 18, 2015
A dendritic nano-sized hexanuclear ruthenium(II) complex as a one- and two-photon luminescent tracking non-viral gene vector
Kangqiang Qiu, Bole Yu, Huaiyi Huang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
February 20, 2025
Platelets promote metastasis of intrahepatic cholangiocarcinoma through activation of TGF-β/Smad2 pathway
Guijuan Luo, Shuyang Zhu, Liujie He, et al.
Scientific Reports
|
April 26, 2025
Frailty, genetic predisposition, and incident chronic kidney disease
Shanshan Zou, Ying Sun, Yinuo Zhou, et al.
Genomics, Proteomics & Bioinformatics
|
August 17, 2017
CYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients
Lin Yang, Shanshan Zou, Chang Shu, et al.
Annals of Palliative Medicine
|
March 11, 2021
Influence of postoperative adjuvant transarterial chemoembolization on the prognosis of early-stage intrahepatic cholangiocarcinoma: a single center study
Guofang Liu, Wei Guo, Hao Wang, et al.
Oncology Letters
|
November 30, 2016
UGT1A1*6, UGT1A7*3 and UGT1A9*1b polymorphisms are predictive markers for severe toxicity in patients with metastatic gastrointestinal cancer treated with irinotecan-based regimens
Chengxu Cui, Chang Shu, Dandan Cao, et al.
Nature Communications
|
December 20, 2014
Mutational landscape of intrahepatic cholangiocarcinoma
Shanshan Zou, Jiarui Li, Huabang Zhou, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
November 8, 2017
Interfering with DNA High-Order Structures using Chiral Ruthenium(II) Complexes
Shanshan Zou, Guanying Li, Thomas W Rees, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2010
Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis
Huabang Zhou, Hui Wang, Dongxun Zhou, et al.
Scientific Reports
|
July 18, 2015
A dendritic nano-sized hexanuclear ruthenium(II) complex as a one- and two-photon luminescent tracking non-viral gene vector
Kangqiang Qiu, Bole Yu, Huaiyi Huang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
February 20, 2025
Platelets promote metastasis of intrahepatic cholangiocarcinoma through activation of TGF-β/Smad2 pathway
Guijuan Luo, Shuyang Zhu, Liujie He, et al.
Scientific Reports
|
April 26, 2025
Frailty, genetic predisposition, and incident chronic kidney disease
Shanshan Zou, Ying Sun, Yinuo Zhou, et al.
Genomics, Proteomics & Bioinformatics
|
August 17, 2017
CYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients
Lin Yang, Shanshan Zou, Chang Shu, et al.
Annals of Palliative Medicine
|
March 11, 2021
Influence of postoperative adjuvant transarterial chemoembolization on the prognosis of early-stage intrahepatic cholangiocarcinoma: a single center study
Guofang Liu, Wei Guo, Hao Wang, et al.
Oncology Letters
|
November 30, 2016
UGT1A1*6, UGT1A7*3 and UGT1A9*1b polymorphisms are predictive markers for severe toxicity in patients with metastatic gastrointestinal cancer treated with irinotecan-based regimens
Chengxu Cui, Chang Shu, Dandan Cao, et al.
Nature Communications
|
December 20, 2014
Mutational landscape of intrahepatic cholangiocarcinoma
Shanshan Zou, Jiarui Li, Huabang Zhou, et al.
Page
of 3